Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
FRACTALKINE GENE RECEPTOR POLYMORPHISM IN PATIENTS WITH MULTIPLE SCLEROSIS.
New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why?
RORs in Autoimmune Disease.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Highlights from the 31st ECTRIMS congress - Barcelona 2015.
Role of Chlamydia in Multiple Sclerosis.
Brain atrophy at onset and physical disability in multiple sclerosis.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors b20-4.1.1 and angiostatin (k1-3).
Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.
Jacksonian seizure as the relapse symptom of multiple sclerosis.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Multiple sclerosis in Syria.
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
[Applications of Optical Coherence Tomography (OCT) in Neuro-ophthalmology.]
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
Pages
« first
‹ previous
…
303
304
305
306
307
308
309
310
311
…
next ›
last »